MY6900059A - Pharmaceutical compositions and a process for the manufacture - Google Patents

Pharmaceutical compositions and a process for the manufacture

Info

Publication number
MY6900059A
MY6900059A MY196959A MY6900059A MY6900059A MY 6900059 A MY6900059 A MY 6900059A MY 196959 A MY196959 A MY 196959A MY 6900059 A MY6900059 A MY 6900059A MY 6900059 A MY6900059 A MY 6900059A
Authority
MY
Malaysia
Prior art keywords
manufacture
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
MY196959A
Original Assignee
F Hoffmann-La Roche & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann-La Roche & Co filed Critical F Hoffmann-La Roche & Co
Publication of MY6900059A publication Critical patent/MY6900059A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heat-Exchange Devices With Radiators And Conduit Assemblies (AREA)
MY196959A 1965-08-20 1969-12-31 Pharmaceutical compositions and a process for the manufacture MY6900059A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1177965 1965-08-20

Publications (1)

Publication Number Publication Date
MY6900059A true MY6900059A (en) 1969-12-31

Family

ID=4376790

Family Applications (1)

Application Number Title Priority Date Filing Date
MY196959A MY6900059A (en) 1965-08-20 1969-12-31 Pharmaceutical compositions and a process for the manufacture

Country Status (14)

Country Link
JP (1) JPS507079B1 (en)
BE (1) BE685589A (en)
DE (1) DE1617513C3 (en)
DK (1) DK111277B (en)
ES (1) ES330391A1 (en)
FI (1) FI45726C (en)
FR (1) FR6063M (en)
GB (1) GB1101366A (en)
IL (1) IL26306A (en)
IT (1) IT1053660B (en)
MY (1) MY6900059A (en)
NL (1) NL6610569A (en)
NO (1) NO120752B (en)
SE (1) SE351978B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
US20020032245A1 (en) * 2000-07-27 2002-03-14 Lyn Hughes Resinate composition
US20030059397A1 (en) * 2001-09-17 2003-03-27 Lyn Hughes Dosage forms
DE60226899D1 (en) * 2002-01-18 2008-07-10 Rohm & Haas USE OF A RESINATE FOR PRODUCING A FORMULATION TO END SMOKING

Also Published As

Publication number Publication date
FI45726C (en) 1972-09-11
FR6063M (en) 1968-05-27
DE1617513A1 (en) 1970-12-23
IL26306A (en) 1970-02-19
DE1617513B2 (en) 1973-08-16
JPS507079B1 (en) 1975-03-20
GB1101366A (en) 1968-01-31
IT1053660B (en) 1981-10-10
FI45726B (en) 1972-05-31
NO120752B (en) 1970-11-30
ES330391A1 (en) 1967-10-16
DE1617513C3 (en) 1974-04-18
SE351978B (en) 1972-12-18
DK111277B (en) 1968-07-15
NL6610569A (en) 1967-02-21
BE685589A (en) 1967-02-17

Similar Documents

Publication Publication Date Title
MY7400317A (en) Halogeno-pregnadienes and process for the manufacture thereof
IL25427A (en) 2-nitro-imidazole derivatives and process for the manufacture thereof
IL24858A (en) Pyrroloindazoles and process for preparing the same
IL23629A (en) 9beta,10alpha-steroids and process for the manufacture thereof
MY6900059A (en) Pharmaceutical compositions and a process for the manufacture
IL26905A (en) Sugar substitute and a process for the preparation thereof
CY466A (en) Novel therapeutic compositions and a process for the manufacture thereof
MY7000126A (en) Pharmaceutical preparations and a process for the manufacture thereof
MY7000111A (en) Benzenesulphonyl-ureas and process for their manufacture
MY7100058A (en) Benzenesulphonyl-ureas and process for their manufacture
IL24853A (en) Dihydrodibenzocycloheptene compounds and process for the manufacture thereof
IL24852A (en) Dihydrodibenzocycloheptene compounds and process for the manufacture thereof
IL25894A (en) Vitamin a containing composition and process for the manufacture thereof
IL25794A (en) Phenyl-propylamines and process for their manufacture
IL26428A (en) 1-phenyl-2-aminoethyl-isoindoline derivatives and process for the manufacture thereof
AU409017B2 (en) Pharmaceutical compositions anda process forthe manufacture thereof
CA717976A (en) Sulfapyrimidines and process for the manufacture thereof
AU405903B2 (en) New n-substituted pyridobenzodiazepines and process for the manufacture thereof
AU6428665A (en) Asphalt-solid compositions and process for the manufacture thereof
IE29341L (en) Pharmaceutical composition
AU407589B2 (en) Novel 1-cycloalkenyl-piperidines and process for the manufacture thereof
CA709415A (en) Unsaturated aliphatic compounds and process for the manufacture thereof
CA720380A (en) 6-methyl-19-nor-steroids and process for the preparation thereof
CA714063A (en) Sulfonamides and process for the manufacture thereof
CA708186A (en) Trithiacyclopentanes and a process for their preparation